BROOKS : BOARD APPROVES DEMERGER OF MANUFACTURING BUSINESS INTO WHOLLY OWNED SUBSIDIARY

• Demerger of Baddi manufacturing business on going-concern basis into Abridge Speciality Limited, a wholly owned subsidiary • Demerged undertaking FY26 turnover ₹828.73 Cr, about 96.66% of Brooks Laboratories total turnover • Share entitlement ratio 1:1; Abridge to issue 2.95 Cr equity shares to Brooks shareholders • Post-scheme promoter and promoter group to hold 52.62% of Abridge, public 47.38% • No cash consideration; Abridge to seek BSE and NSE listing, expected about 16 months from filing • Both platforms to have expected capital availability of ~₹50 Cr each for strategic growth and expansion

Brooks Laboratories Ltd

Open attachment

← Back to feed